Taiwan Entering Global Life Science Arena

17 Jan

By Jessica Yang, Investor Research Analyst, LSN

Back in October 2018, LSN cooperated with BIOMED Taiwan and the Biomedical Commercialization Center to hold a three-day Biotech/Medtech Startups Fundraising & Entrepreneurship Training Bootcamp in Taiwan. This event was held to help bring Taiwan’s biomedical startups to the international stage and to give the companies a chance to learn how to seek fundraising opportunities. Dennis Ford, LSN Founder and CEO, Greg Mannix, VP of International Business Development, and Jessica Yang, Senior Investor Research Analyst & Asia BD were invited to visit Taiwan to teach the Bootcamp as well as provide one-on-one startup fundraising consultations. This was the first time that Taiwan’s biomedical industry has cooperated in holding a fundraising training program with an international early-stage startup fundraising consulting firm, such as LSN.

On Oct 16, 2018, the first day of the training program, Dennis gave a top-to-bottom master class on outbound global fundraising campaigning to over 90 Taiwanese biomedical startups. Topics included the changing investor landscape, new categories of life science investors, and how to organize and execute a successful roadshow. This class also took companies through positioning, marketing collateral, website creation, branding & messaging, and how to reach out to a target list of global investors. Greg talked about the strategies for searching for global investors and running an investor meeting, including how to source investor leads and how to understand and determine investor fits. In the afternoon, Jessica gave a presentation on how to successfully apply to startup competitions such as RESI Innovation Challenge, including what makes a good Innovation Challenge application. Overall the Bootcamp received a very positive reception on its solid content and unique strategies. Over the next two days, Dennis, Greg, and Jessica sat with 20 teams, giving one-on-one consultations to help teams with their fundraising strategies and marketing collateral.

The three-day training program served the companies as a warm-up to RESI SF. A total of 15 teams signed up for this RESI Conference, and 5 teams were chosen by the LSN scientific review team to participate in the Innovation Challenge. After the fundraising training program in Taiwan, a Taiwanese medtech company, Heroic Faith, won the second prize in Innovation Challenge at last week’s RESI. Its novel approach to support critical care medical practitioners to cope with lung-related complications would greatly enhance medical care efficiency and reduce mortality.

In addition, BioMed Taiwan and the Biomedical Commercialization Center have specially cooperated with LSN to organize the Taiwan Luncheon & Pitching Event at the RESI conference to help bring exposure to biomedical startups from Taiwan. BioMed Taiwan has selected some of the most outstanding startups to take the stage to present their products, effectively promoting them in the international arena.

Other startups among the total of fifteen from Taiwan presented innovations ranging from robotics to tissue regeneration, covering medical devices and pharmaceuticals, attracted impressive remarks from the audience during the occasion. The fifteen included Above Care, Acusense, All Bio, ATP BioPharm, Flat Medical, Free Bionics, Heroic Faith, MTAM Tech, Papivax Biotech, Point Robotics, PressureDOT Technology, Taipei Bio, Taiwan Resonant Waves Research Corp, Ultrondata Driven, and WeMED Biotech. This marked an opportunity for these Taiwanese startups to increase their visibility on the international stage.

BioMed TW also sponsored LSN to arrange a “Taiwan Investors” panel session. Dr. Michel Chu, Chief Innovation Officer of BioMed TW and Jessica had invited several renowned international investment experts to join the forum to discuss the strengths and opportunities associated with Taiwan’s biomedical industry environment. International venture capitalists, multinational enterprises, and startups were invited to Taiwan to pursue a broad range of cooperative opportunities.

Dr. Woei-Jer Chuang, the Director General of Department of Life Sciences of Taiwan Ministry of Science & Technology as well as the Executive Secretary of BioMed TW remarked that the objective of the event was to introduce Taiwan’s achievements and investment environment in biotech and healthcare to international investors and enterprises. He pointed out that Canada, Israel, and Korea have held similar events to promote their countries. Those activities proved to be quite success. LSN was delighted to work with all of those involved in making the Bootcamp and Taiwanese delegation and luncheon at RESI a success, and looks forward to continuing this partnership to bring the amazing technologies developed in Taiwan further into the spotlight!


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: